KRM Ayurveda Ltd has scheduled an investor and analyst meet to engage with the investment community. The meeting is set to take place on June 23, 2026, at Grand Hyatt, Mumbai. This interaction provides a platform for the company's leadership to discuss business performance and strategy directly with market participants.

The session is organized by PhillipCapital (India) Private Limited and will be conducted in physical mode from 9:00 A.M. to 2:00 P.M. The meeting is classified as a group interaction, allowing multiple institutional investors to participate. The company has specified that the schedule remains subject to change due to exigencies on the part of investors or the company.

Mr. Puneet Dhawan, Managing Director of KRM Ayurveda Ltd, will represent the company during the proceedings. The disclosure regarding the meeting was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

In its filing, the company clarified that no unpublished price sensitive information (UPSI) pertaining to KRM Ayurveda Ltd will be shared during the meeting. This assurance covers interactions with various institutional investors, including Mutual Funds, Insurance Funds, AIF/PMS, Alternative Investments, and Private Equity Funds.

The key details of the investor meet are outlined below:

KRM Ayurveda Ltd has established MSS Hospital, a new unit in Pitampura, New Delhi, to expand its Ayurvedic healthcare services. The facility, located at Zone H-4-5, Plot No. 5-6-7, Parwana Road, Delhi-110034, will operate as an Ayurvedic hospital and clinic providing both In-Patient Department (IPD) and Out-Patient Department (OPD) services. This strategic expansion aims to strengthen the company's presence in the Ayurvedic healthcare sector.

The hospital is equipped with 23 beds and covers a total area of 5631 sq. ft. The establishment of this unit is part of the company's broader objective to enhance its service offerings and accessibility in the region.

Details of MSS Hospital

The disclosure was made to the National Stock Exchange of India Ltd in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Sanchit Hans, Whole-Time Director of KRM Ayurveda Ltd, signed the intimation on June 16, 2026.